Fingerprint
Dive into the research topics of 'A phase I study of cixutumumab (IMC-A12) in combination with temsirolimus (CCI-779) in children with recurrent solid tumors: A Children's Oncology Group phase I consortium report'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically